Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis

Background: Lacking head-to-head trial, the optimal treatment for patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel failure is unclear. This study is to compare the efficacy and safety of systemic treatments in patients who progressed after docetaxel to aid clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junru, Zhang, Yaowen, Zhang, Xingming, Zhao, Jinge, Ni, Yuchao, Zhu, Sha, He, Ben, Dai, Jindong, Wang, Zhipeng, Wang, Zilin, Liang, Jiayu, Zhu, Xudong, Shen, Pengfei, Zeng, Hao, Sun, Guangxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804311/
https://www.ncbi.nlm.nih.gov/pubmed/35115934
http://dx.doi.org/10.3389/fphar.2021.789319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804311/
https://www.ncbi.nlm.nih.gov/pubmed/35115934
http://dx.doi.org/10.3389/fphar.2021.789319

Ejemplares similares